Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease.

Leskovjan AC, Lanzirotti A, Miller LM.

Neuroimage. 2009 Oct 1;47(4):1215-20. doi: 10.1016/j.neuroimage.2009.05.063. Epub 2009 May 28.

2.

Redox-active metals, oxidative stress, and Alzheimer's disease pathology.

Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT.

Ann N Y Acad Sci. 2004 Mar;1012:153-63. Review.

PMID:
15105262
3.

The redox chemistry of the Alzheimer's disease amyloid beta peptide.

Smith DG, Cappai R, Barnham KJ.

Biochim Biophys Acta. 2007 Aug;1768(8):1976-90. Epub 2007 Feb 9. Review.

4.

Metals and amyloid-beta in Alzheimer's disease.

Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX.

Int J Exp Pathol. 2005 Jun;86(3):147-59. Review.

5.

Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.

Tõugu V, Tiiman A, Palumaa P.

Metallomics. 2011 Mar;3(3):250-61. doi: 10.1039/c0mt00073f. Epub 2011 Feb 25. Review.

PMID:
21359283
6.

The metallobiology of Alzheimer's disease.

Bush AI.

Trends Neurosci. 2003 Apr;26(4):207-14. Review.

PMID:
12689772
7.

Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer.

Faller P.

Chembiochem. 2009 Dec 14;10(18):2837-45. doi: 10.1002/cbic.200900321. Review.

PMID:
19877000
8.

Alzheimer's disease, metal ions and metal homeostatic therapy.

Zatta P, Drago D, Bolognin S, Sensi SL.

Trends Pharmacol Sci. 2009 Jul;30(7):346-55. doi: 10.1016/j.tips.2009.05.002. Epub 2009 Jun 17. Review.

PMID:
19540003
9.

Metal-associated amyloid-β species in Alzheimer's disease.

Pithadia AS, Lim MH.

Curr Opin Chem Biol. 2012 Apr;16(1-2):67-73. doi: 10.1016/j.cbpa.2012.01.016. Epub 2012 Feb 25. Review.

PMID:
22366383
10.

Therapeutics for Alzheimer's disease based on the metal hypothesis.

Bush AI, Tanzi RE.

Neurotherapeutics. 2008 Jul;5(3):421-32. doi: 10.1016/j.nurt.2008.05.001. Review.

11.

MR microimaging of amyloid plaques in Alzheimer's disease transgenic mice.

Wengenack TM, Jack CR Jr, Garwood M, Poduslo JF.

Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S82-8. doi: 10.1007/s00259-007-0706-9. Review.

PMID:
18239918
12.

Metal and complementary molecular bioimaging in Alzheimer's disease.

Braidy N, Poljak A, Marjo C, Rutlidge H, Rich A, Jayasena T, Inestrosa NC, Sachdev P.

Front Aging Neurosci. 2014 Jul 15;6:138. doi: 10.3389/fnagi.2014.00138. eCollection 2014. Review.

13.

Novel drug targets based on metallobiology of Alzheimer's disease.

Bandyopadhyay S, Huang X, Lahiri DK, Rogers JT.

Expert Opin Ther Targets. 2010 Nov;14(11):1177-97. doi: 10.1517/14728222.2010.525352. Review.

PMID:
20942746
14.

[The role of copper in the pathophysiology of Alzheimer's disease].

Kessler H, Pajonk FG, Supprian T, Falkai P, Multhaup G, Bayer TA.

Nervenarzt. 2005 May;76(5):581-5. Review. German.

PMID:
15905983
15.

Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease.

Cristóvão JS, Santos R, Gomes CM.

Oxid Med Cell Longev. 2016;2016:9812178. doi: 10.1155/2016/9812178. Epub 2016 Jan 10. Review.

16.

The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.

Peters DG, Connor JR, Meadowcroft MD.

Neurobiol Dis. 2015 Sep;81:49-65. doi: 10.1016/j.nbd.2015.08.007. Epub 2015 Aug 22. Review.

17.

Effect of metals on kinetic pathways of amyloid-β aggregation.

Hane F, Leonenko Z.

Biomolecules. 2014 Jan 10;4(1):101-16. doi: 10.3390/biom4010101. Review.

18.

The Role of Presenilin in Protein Trafficking and Degradation-Implications for Metal Homeostasis.

Greenough MA.

J Mol Neurosci. 2016 Nov;60(3):289-297. Epub 2016 Aug 25. Review.

PMID:
27558108
19.

Kynurenines, neurodegeneration and Alzheimer's disease.

Kincses ZT, Toldi J, Vécsei L.

J Cell Mol Med. 2010 Aug;14(8):2045-54. doi: 10.1111/j.1582-4934.2010.01123.x. Epub 2010 Jul 12. Review.

20.

Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures.

Myhre O, Utkilen H, Duale N, Brunborg G, Hofer T.

Oxid Med Cell Longev. 2013;2013:726954. doi: 10.1155/2013/726954. Epub 2013 Apr 17. Review.

Supplemental Content

Support Center